Valeant nears deal to buy Salix for about $10 billion: WSJ

Sat Feb 21, 2015 4:25pm EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

(Reuters) - Valeant Pharmaceuticals International (VRX.TO: Quote) is near a deal to buy Salix Pharmaceuticals Ltd SLXP.O for about $10 billion, the Wall Street Journal reported on Saturday.

(Reporting by Eric Beech)

 
The head offices of Valeant Pharmaceuticals International Inc. are seen in Laval, Quebec May 20, 2014. REUTERS/Christinne Muschi